Showing results (2701-2710 of 2,709) with videos related to

Sort By:
Pageof 271
You have reached the last page of results.This site can display upto 2,709 results.
The Lancet. Infectious Diseases|August 20, 2026
Azithromycin with or without cefixime for suspected or culture-confirmed uncomplicated typhoid fever in Nepal, Bangladesh, and Pakistan (ACT-South Asia): a double-blind, parallel-group, randomised, placebo-controlled, phase 4 trialBuddha Basnyat, Sudeep Adhikari, Puja Shrestha, et al.
The Lancet. Infectious Diseases|August 31, 2026
Clinical accuracy, performance, and usability of the Dragonfly point-of-care molecular diagnostic platform for mpox: a mixed-methods field evaluation in UgandaBarnabas Bakamutumaho, Kevin Baker, Matthew L Cavuto, et al.
The Lancet. Infectious Diseases|September 10, 2026
Immunogenicity and safety of an MF59-adjuvanted cell-derived higher-dose quadrivalent influenza vaccine (aQIVc) in adults aged 50 years or older: a phase 3 randomised controlled trialBrandon J Essink, Wim Vermeulen, Coralie Andrade, et al.
The Lancet. Infectious Diseases|September 2, 2026
Sepsis, endemic and emerging infectious diseases: converging concepts and clinical implicationsReinaldo Salomão, Giuseppe G F Leite, Matias C Salomão, et al.
The Lancet. Infectious Diseases|September 2, 2026
Accelerated qualification of diagnostic tests during an ongoing outbreak of Bundibugyo virus disease: a collaborative analytical validation studyTill Dominik Best, Lisa Oestereich, Francesca Colavita, et al.
The Lancet. Infectious Diseases|October 12, 2026
Efficacy, safety, and immunogenicity of a nine-valent vaccine (ExPEC9V) for the prevention of invasive Escherichia coli disease in older adults: a phase 3, randomised, placebo-controlled trial (E.mbrace)Marc Bonten, Christopher C Butler, Andrew Edwards, et al.
The Lancet. Infectious Diseases|September 22, 2026
Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trialCristina Alonso-Vega, Jimy José Pinto Rocha, Licet Gimena Rojas Delgadillo, et al.
The Lancet. Infectious Diseases|October 23, 2026
Safety and immunogenicity of an adenoviral-vectored vaccine against Crimean-Congo haemorrhagic fever in the UK (CCHF01): an open-label, first-in-human, non-randomised, phase 1 clinical trialKatrina M Pollock, Jack E Saunders, Jamie Fowler, et al.
The Lancet. Infectious Diseases|November 6, 2026
Ganaplacide plus lumefantrine solid dispersion formulation for children with uncomplicated Plasmodium falciparum malaria (KALUMI): an open-label, multicentre, randomised, controlled, adaptive, phase 2, non-inferiority trialBakary Fofana, Rella Zoleko-Manego, Ghyslain Mombo-Ngoma, et al.
Pageof 271